Intellipharmaceutics (IPCI) Forum
Sign up Calendar Latest Topics

  Author   Comment  

Posts: 725
Reply with quote  #1 
Well Folks, it appears there could be a settlement in works.  No guarantee but it they must be talking.  The case is postponed.  They scheduled a Phone conference Dec 17 to "determine the status of the case"  

Could it be, that they are working a partnership and the partner wanted the case settled before agreeing to signing?   It would make sense.  we all know Purdue, even if they lost would have just filed an appeal to keep things stalled.   any partner may have said, settle before I sign.    Don't know.

As previously announced, on April 7, 2017, Intellipharmaceutics International Inc. (the “Company”) received notice that Purdue Pharma L.P., Purdue Pharmaceuticals L.P., The P.F. Laboratories, Inc., Rhodes Technologies, and another party had commenced patent infringement proceedings against the Company in the U.S. District Court for the District of Delaware in respect of the Company’s new drug application filing for Oxycodone ER. A trial date was set for October 22, 2018.
On October 4, 2018, the parties to the case mutually agreed to postpone the scheduled court date pending a case status conference scheduled for December 17, 2018. 
Previous Topic | Next Topic

Quick Navigation:

Easily create a Forum Website with Website Toolbox.